Clonidine
Clonidine is a central alpha-2 agonist, a medicine that acts on the brain stem to lower blood pressure. The US label read, for generic clonidine hydrochloride tablets taken by mouth, lists the treatment of hypertension, alone or together with other blood pressure medicines. The label says it stimulates alpha-adrenoreceptors in the brain stem, which reduces sympathetic outflow (nerve signals of the sympathetic system) from the central nervous system.
Also called Clonidine hydrochloride
- Drug
- In this atlas
Overview
Technical summary
RxNorm ingredient 2599 (clonidine hydrochloride is 142432); UNII W76I6XXF06 is the UNII of the hydrochloride salt that the label gives, so it is a broad match. MeSH descriptor D003000 is Clonidine. RxClass lists the FDA established pharmacologic class Central alpha-2 Adrenergic Agonist; the record is filed under the class page for alpha-adrenergic blockers and central alpha-2 agonists on that evidence. The label read is the Unichem Pharmaceuticals (USA), Inc. generic tablet label, application ANDA078895, effective 2026-03-30 in openFDA. The plan row pointed at a repackager label (RemedyRepack); the manufacturer's label replaces it. The transdermal system (Catapres-TTS, read for the class page), the injection and the combination products that contain clonidine were not read. This page records the label indication, the class sentence and the mechanism sentence only: no trial result and no dose is given.
About this drug
- Level
- Substance
- Mechanism
- The label says clonidine stimulates alpha-adrenoreceptors in the brain stem, which reduces sympathetic outflow from the central nervous system.
Classification codes
-
W76I6XXF06
Claims and evidence
Context People with hypertension, as described in the US label of generic clonidine hydrochloride tablets
- Recipient
- Recipient not specified
- Population
- Patients with hypertension, as the indications section of the label states. The label passages read do not state an age range.
- Care setting
- Prescription medicine, as described in the US label
- Geography
- United States (label of the US Food and Drug Administration)
- Life stage
- Not stated in the label passages read
- Gestational age
- Not reported
- Postnatal age
- Not reported
- Follow-up
- Not applicable (label statement)
Eligibility: 1 inclusion criterion; exclusion criteria not stated
- Included
- Patients with hypertension
- Excluded
- None stated
The US label of clonidine hydrochloride tablets (Unichem Pharmaceuticals (USA), Inc., application ANDA078895; the version dated 2026-03-30 in openFDA) lists the treatment of hypertension, and says the tablets may be used alone or together with other antihypertensive agents. It calls clonidine hydrochloride a centrally acting alpha-agonist hypotensive agent and says it stimulates alpha-adrenoreceptors in the brain stem, which reduces sympathetic outflow from the central nervous system.
Applies to Recipient not specified People with hypertension, as described in the US label of generic clonidine hydrochloride tablets
- Certainty method
- Not assessed
- Limitations
- This claim records what one US label says the medicine is indicated for and how it describes the medicine. It is not a finding about how well the medicine works, and no trial result is recorded for it in this atlas. The label is for a generic oral tablet; the transdermal system, the injection and the combination products that contain clonidine were not read. The label passages read state no age range except where the claim says adults. Contraindications, warnings, interactions, use in pregnancy and in children, and dosing were not recorded. Labels change, and openFDA lists other versions with different dates. openFDA's own disclaimer says not to rely on it for decisions about medical care.
- Last checked
- 2026-11-18
- Next evidence check due
- Not scheduled
Sources and citations (5)
-
- Locator
- results[0].openfda.application_number[0]
- How it applies
- Application number of the label read.
- Retrieved
- Source effective date
- 2026-03-30
- Source state
- Current
- Version fingerprint
5965a91978ed01811ca891733b356868a6d4a837fe719d5bc39ca8da7b5d53ae- Reuse basis
- openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-11-18, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only). Only short passages are quoted. The raw record is committed in the atlas repository.
-
- Locator
- results[0].effective_time
- How it applies
- Effective date of the label text read.
- Retrieved
- Source effective date
- 2026-03-30
- Source state
- Current
- Version fingerprint
5965a91978ed01811ca891733b356868a6d4a837fe719d5bc39ca8da7b5d53ae- Reuse basis
- openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-11-18, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only). Only short passages are quoted. The raw record is committed in the atlas repository.
-
- Locator
- results[0].indications_and_usage[0]
- How it applies
- Label passage quoted in the research quote table (CLO-LB-04, CLO-LB-05).
- Retrieved
- Source effective date
- 2026-03-30
- Source state
- Current
- Version fingerprint
5965a91978ed01811ca891733b356868a6d4a837fe719d5bc39ca8da7b5d53ae- Reuse basis
- openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-11-18, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only). Only short passages are quoted. The raw record is committed in the atlas repository.
-
- Locator
- results[0].description[0]
- How it applies
- Label passage quoted in the research quote table (CLO-LB-06).
- Retrieved
- Source effective date
- 2026-03-30
- Source state
- Current
- Version fingerprint
5965a91978ed01811ca891733b356868a6d4a837fe719d5bc39ca8da7b5d53ae- Reuse basis
- openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-11-18, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only). Only short passages are quoted. The raw record is committed in the atlas repository.
-
- Locator
- results[0].clinical_pharmacology[0]
- How it applies
- Label passage quoted in the research quote table (CLO-LB-07).
- Retrieved
- Source effective date
- 2026-03-30
- Source state
- Current
- Version fingerprint
5965a91978ed01811ca891733b356868a6d4a837fe719d5bc39ca8da7b5d53ae- Reuse basis
- openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-11-18, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only). Only short passages are quoted. The raw record is committed in the atlas repository.
Clinical links
Each link reports what one cited claim says about one population. "Evaluated for" means studied, not shown to work. These links do not show that anything is effective or right for you.
-
Claim, not a settled fact FDA label lists the treatment of hypertension, alone or with other antihypertensive agents, as the indication: Hypertension (high blood pressure)
Applies to Recipient not specified People with hypertension, as described in the US label of generic clonidine hydrochloride tablets
The US label of clonidine hydrochloride tablets (Unichem Pharmaceuticals (USA), Inc., application ANDA078895; the version dated 2026-03-30 in openFDA) lists the treatment of hypertension, and says the tablets may be used alone or together with other antihypertensive agents. It calls clonidine hydrochloride a centrally acting alpha-agonist hypotensive agent and says it stimulates alpha-adrenoreceptors in the brain stem, which reduces sympathetic outflow from the central nervous system.Limitations. This claim records what one US label says the medicine is indicated for and how it describes the medicine. It is not a finding about how well the medicine works, and no trial result is recorded for it in this atlas. The label is for a generic oral tablet; the transdermal system, the injection and the combination products that contain clonidine were not read. The label passages read state no age range except where the claim says adults. Contraindications, warnings, interactions, use in pregnancy and in children, and dosing were not recorded. Labels change, and openFDA lists other versions with different dates. openFDA's own disclaimer says not to rely on it for decisions about medical care.
Record details
- Record id
cardio:clonidine- Content hash
1bdbad51d653e4596e8dfa2014d450e99f2575c23fa3e1246094ae24c38c3373